Masimo And Royal Philips Announce FDA Clearance Allowing The Activation Of SedLine, Brain Function Monitoring, Regional Oximetry And CO2 Measurements In Philips Patient Monitors IntelliVue MX750 And MX850
Portfolio Pulse from Benzinga Newsdesk
Masimo and Royal Philips announced FDA clearance for the activation of SedLine, brain function monitoring, regional oximetry, and CO2 measurements in Philips Patient Monitors IntelliVue MX750 and MX850. This will enhance patient monitoring capabilities.
June 01, 2023 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Masimo receives FDA clearance for advanced monitoring features in partnership with Royal Philips, potentially boosting sales.
The FDA clearance allows Masimo to offer advanced monitoring features in partnership with Royal Philips. This could lead to increased sales and market share for Masimo, positively impacting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Royal Philips receives FDA clearance for advanced monitoring features in IntelliVue MX750 and MX850, potentially increasing product demand.
The FDA clearance allows Royal Philips to offer advanced monitoring features in its IntelliVue MX750 and MX850 patient monitors. This could lead to increased demand for these products, positively impacting Royal Philips' stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50